Study uses extra blood samples for solid cancer patients
Part of Cancer clinical trials.
This study looks at how blood can help us better understand solid cancers. You may be able to join if you’re an adult with solid cancer and your usual care already involves taking blood, and you can safely provide samples for the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (age 18 or older)
- You have a solid cancer diagnosis confirmed by lab testing (tissue or cell testing)
- Your usual cancer care requires blood sampling (as standard care)
- You agree to take part and sign the informed consent form
- Your body weight is at least 20 kg (about 44 lb)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at a specific type of immune cell (called TLR4+ cells) in the blood of people with solid tumors. By studying these cells, researchers hope to learn more about how the immune system reacts to cancer and to treatments.
This study is looking at a blood marker (a type of chemical change in cells) to see if it can help predict how solid tumor cancers will behave. If you have a solid tumor cancer, this research might help doctors understand your condition better.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This study collects blood and may also use existing tumor tissue to help develop a liquid biopsy blood test for people with solid (non-blood) cancers. You may qualify if you have a current cancer with tumor in the body and can provide blood samples at set visits.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
Hear when a new Adult With Solid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.